Polycystic Kidney Disease Translating Mechanisms into Therapy /
This comprehensive guide to polycystic kidney disease captures the growing knowledge of this common, potentially-fatal and hereditary disease. The first two sections of the book provide an overview of PKD gene structures, mutations and pathophysiologic mechanisms. This is followed by chapters focuse...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
New York, NY :
Springer New York : Imprint: Springer,
2018.
|
| Έκδοση: | 1st ed. 2018. |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- PART 1. POLYCYSTIC KIDNEY DISEASE GENES & PROTEINS
- 1. Classical Polycystic Kidney Disease (PKD): Gene Structures and Mutations and Protein Structures and Functions
- 2. Bardet-Biedl Syndrome
- 3. Cystic Kidney Diseases Associated with Increased Cancer Risk: Tuberous Sclerosis Complex, Von Hippel Lindau, and Birt Hogg Dubé
- PART 2. POLYCYCSTIC KIDNEY DISEASE: MECHANISMS OF DISEASE
- 4. Aberrant Cellular Pathways in PKD
- 5. Cilia and Polycystic Kidney Disease
- 6. The Role of Inflammation and Fibrosis in Cystic Kidney Disease
- PART 3. CLINICAL FEATURES
- 7. Imaging-based Diagnosis of Autosomal Dominant Polycystic Kidney Disease
- 8. Renal Structural Involvement in Autosomal Dominant Polycystic Kidney Disease: Cyst Growth and Total Kidney Volume: Lessons from the Consortium for Radiologic Imaging of Polycystic Kidney Disease (CRISP)
- 9. Renal Complications: Pain, Infection and Nephrolithiasis
- 10. ADPKD Extrarenal Manifestations: Polycystic Liver Disease
- 11. Extrarenal Manifestations of Autosomal Dominant Polycystic Kidney Disease
- PART 4. CLINICAL TRIALS AND EMERGING THERAPIES
- 12. Role of Renin- Angiotensin- Aldosterone System Inhibition in Autosomal Dominant Polycystic Kidney Disease
- 13. Vasopressin Receptor Antagonism
- 14. End-stage Renal Disease in Patients with Autosomal Dominant Polycystic Kidney Disease
- 15. Polycystic Kidney Disease: Translating Mechanisms into Therapy Management of ADPKD Today.